000			01926 a2200517 4500
005			20250516180020.0
264		0	_c20140714
008			201407s 0 0 fre d
022			_a1166-7087
024	7		_a10.1016/j.purol.2013.08.322 _2doi
040			_aNLM _beng _cNLM
100	1		_aMongiat-Artus, P
245	0	0	_a[The non-hormonal treatment of metastatic prostate cancer]. _h[electronic resource]
260			_bProgres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie _cNov 2013
300			_a1258-64 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xeconomics
650	0	4	_aBone Density Conservation Agents _xtherapeutic use
650	0	4	_aCisplatin _xeconomics
650	0	4	_aDenosumab
650	0	4	_aDocetaxel
650	0	4	_aEtoposide _xeconomics
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMitoxantrone _xeconomics
650	0	4	_aOrganometallic Compounds _xeconomics
650	0	4	_aOrganophosphorus Compounds _xeconomics
650	0	4	_aOsteoporosis _xetiology
650	0	4	_aProstatic Neoplasms _xpathology
650	0	4	_aRANK Ligand _xantagonists & inhibitors
650	0	4	_aRadiation Protection _xmethods
650	0	4	_aRadioisotopes _xeconomics
650	0	4	_aRadium _xeconomics
650	0	4	_aStrontium _xeconomics
650	0	4	_aStrontium Radioisotopes _xeconomics
650	0	4	_aTaxoids _xeconomics
700	1		_aBrenot-Rossi, I
700	1		_aBeuzeboc, P
700	1		_aBruyère, F
700	1		_aKarsenty, G
700	1		_aGuy, L
700	1		_aBastide, C
773	0		_tProgres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie _gvol. 23 _gno. 15 _gp. 1258-64
856	4	0	_uhttps://doi.org/10.1016/j.purol.2013.08.322 _zAvailable from publisher's website
999			_c23222753 _d23222753